Solara Active Pharma Reports Mixed Financial Results Amid Sales Decline in March 2025

May 15 2025 07:05 PM IST
share
Share Via
Solara Active Pharma Sciences has announced its financial results for the quarter ending March 2025, showing a Profit After Tax of Rs 5.99 crore, a significant year-on-year increase. However, net sales declined to Rs 273.01 crore, marking the lowest figure in five quarters, alongside uncertain non-operating income.
Solara Active Pharma Sciences has recently reported its financial results for the quarter ending March 2025, revealing a mix of positive and challenging trends. The company's Profit After Tax (PAT) for the latest six months stands at Rs 5.99 crore, reflecting a significant year-on-year growth of 101.73%. This marks a notable turnaround, as the PAT has surpassed the preceding twelve-month period, which recorded a loss of Rs 351.18 crore.

However, the company has faced challenges in its net sales, which totaled Rs 273.01 crore for the quarter. This figure represents a decline of 16.6% compared to the average net sales of the previous four quarters, making it the lowest sales figure recorded in the last five quarters. Additionally, while non-operating income reached Rs 5.95 crore, the sustainability of this income from non-business activities remains uncertain.

In light of these developments, Solara Active has experienced an adjustment in its evaluation, with its score reflecting these recent changes.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News